The human interleukin-2-receptor is a glycopeptide of an apparent molecular weight of 55kD. By chemoenzymatic gene synthesis we constructed the underlying gene consisting of 753 nucleotide base pairs. 38 oligonucleotides varying in length from 27 to 51 bases were joined at their free overlapping ends of 6 to 9 bases by T4 ligase. The resulting gene, subcloned into three pieces was sequenced for its correctness. For subsequent modifications several restriction enzyme cutting sites were introduced synthetically. For expression of this gene in E. coli different B-galactosidase fusion constructions were tested. In addition the synthesis of the glycoprotein will be studied by introducing this gene into higher cells where it can be directly compared to the natural sequence in structure function studies.
INTRODUCTION
The human immune system is prepared to recognize an almost unlimited variety of antigens. Within this framework thymus-derived lymphocytes (T-cells) do get in contact with foreign antigens via the T-cell--receptor. A consequence of this event is the liberation of a T-cell growth factor, the so called lymphokine interleukin-2 (IL-2) (Ref. 1, 2) . In order to be biologically active this IL-2 must interact with a specific membrane receptor on the surface of T-cells, the interleukin-2-receptor (IL-2-Rec) (Ref. 3, 4) . This receptor is not present on resting T-cells but is rapidly expressed after activation with an antigen (Ref. 5 ). Since neither IL-2 nor IL-2-Rec are expressed constitutively the induction of these two genes is of vital importance to the immune response. Recently by the help of anti-Tac (Ref. 6) monoclonal antibody and recombinant DNA-techniques, the cDNA coding for IL-2-Rec was identified (Ref. 7, 8, 9) . This gene consits of 753 base-pairs which code for a glycopeptide of 55kD. The precursor protein a 33kD peptide is coor posttranslationally N-and 0-glycosylated, phosphorylated (Ref. 10 ) and sulfated (Ref.ll) to the apparent molecular weight. In addition the genomic DNA-structure (Ref. 12, 13) consisting of eight exons on chromosome 10 was elucidated. This DNA includes a leader sequence of 63 base pairs which is cleaved off during maturation of the protein. In order to get some insight into the complicated events which govern the interaction of IL-2 and IL-2-Rec we have devised a synthetic gene allowing easy modifications by mutations to elucidate structure function relationsships of modified proteins.
CHEMOENZYMATIC GENE SYNTHESIS
Our gene synthesis is based on the chemical synthesis of the appropriate oligonucleotides which are joined enzymatically (Ref.14) . On the basis of the published DNA and protein sequence (Ref. 7, 8, 9) we constructed our gene but added some especially designed features for future handling. This results in a module system which allows for future modifications including exploratory and functional ones. The total gene consits of 753 base pairs and is divided into three DNA-segments (s. units T4-ligase added. The course of the reaction was followed by gel electrophoresis, checking the ligation mixture against DNA-duplexes of known size. For fragments I-Ill the expected DNA-duplex could be identified isolated by gel electrophoresis, desalted and lyophilized. The three segments IL-2-Rec I-Ill were then cloned in a pUC plasmid (Ref. 19) in an E. coli K12 derivative (Fig.3 ). Due to a frame shift mutation and an additional stop codon in pUC8 and 9 the colonies harbouring the plasmide with the IL-2-Rec I -III inserts were white. Sal I Fig.3 
::i: : secondary structure e.g. Met-øAla (B-sheet), Met-Leu (Helix).
expression of our synthetic gene in E. coli the construction was shown in (Fig.7) .
In this plasmid the IL-2 Rec gene is joined carboxyterminally to either the total B-galactosidase gene or part of it. We have chosen this fusion construction in order to mask the hydrophobic transmembrane region, of the IL-2
Rec by the B-galactosidase moiety. This approach tries to circumvent the potential detrimental incorporation of the transmembrane region into the E. coli membrane. All these new constructions had to be verified by sequencing (Ref.20) and showed the correct DNA-sequence.
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The above fusion constructions were transformed into an E. coli wild-type strain and the 8-galactosidase production was induced by Isopropylthio-B-Dgalactoside. This reaction could be followed by lysing the cells with ultrasonification and directly applying an aliquot of the protein mixture onto a 10% SDS-polyacrylamide gel, using the appropriate size standards. Here we observed a total lack of any detectable fusion protein in the expected size range. Based on our assumption, that the highly hydrophobic membrane •region was responsible for this phenomenon, we also constructed a receptor Bgalactosidase gene fusion which only consisted of the assumed extracellular receptor part. Beside the expression in E. coli which should result in the naked receptor protein we also initiated the gene construction for the expression of the gene in mammalian cells. Since the interleukin 2-receptor in mammalian cells is synthesized as a precursor having a leader sequence we first added the authentic leader (Ref. 7, 8, 9) sequence to our synthetic gene (Fig.8) .
MET Work is in progress to study the various fusion constructions in E. coli and to monitor the synthesis of the IL-2 receptor in mouse L-cells.
The goal of our work is ultimately to study ligand receptor interaction in vitro including artificial membrane vesicles. We hope to achieve this by synthesising the receptor gene as an ample reservoir of the receptor protein in its natural and mutated form. The next step will include the synthesis of modified receptor proteins in E. coli and the synthesis of authentic receptor protein th mammalian cells. Comparison between these two receptors in their binding efficiency to IL-2 will give us an insight into the structural prerequisites for high efficiency binding. Mosaic structures between modified and authentic receptors are under construction to further elucidate the structure function relationship of IL-2 receptor and IL-2.
